Transcriptome-wide identification and competitive disruption of sacum-binding partners in human colorectal cancer

Yinguang Zhang1, Yongwang Zhang2, Yuxiang Zhang3

  • 1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.

Insights

This study identifies human sacum binding partners in colorectal cancer, revealing potential therapeutic targets. We found specific protein interactions that could be disrupted to inhibit cancer signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Human sacum is a regulatory adaptor protein implicated in colorectal cancer signaling.
  • Sacum interacts with SH3-containing proteins via its proline-rich motifs, integrating into oncogenic networks.

Purpose of the Study:

  • To perform a transcriptome-wide analysis identifying sacum-binding partners in human colorectal cancer.
  • To investigate the binding affinity of SH3-containing proteins to sacum using bioinformatics and molecular analysis.
  • To identify potential therapeutic peptides that disrupt sacum-protein interactions.

Main Methods:

  • Transcriptome-wide analysis for sacum-binding partner identification.
  • Bioinformatics modeling and intermolecular binding analysis for SH3-containing proteins.
  • High-throughput prediction of domain-peptide binders and sequence-specific interaction analysis.
  • Case study using Src SH3 domain and design of peptide variants.

Main Results:

  • Identification of numerous high-affinity and specific domain binders for human sacum peptides.
  • Validation of binding activity for the Src SH3 domain with sacum peptides.
  • Design of two peptide variants with potential to disrupt sacum-protein interactions.

Conclusions:

  • Sacum plays a key role in colorectal cancer signaling through interactions with SH3-containing proteins.
  • This study provides a method for high-throughput identification of sacum-binding partners.
  • Identified peptide variants offer a potential therapeutic strategy for colorectal cancer by disrupting oncogenic signaling.

Related Concept Videos